Sunday, March 29, 2015

All Posts

Dr. Bill Quick

Dr. Bill Quick, Health Pro

Physician who is living with diabetes; editor of

The Latest “Me-Too” Insulin Product

The manufacturer of a very popular insulin product, Lantus (insulin glargine), has a problem.The drug, which had 5.72 billion euros ($7.7 billion) in sales last year, loses patent protection soon. Typically, when a drug goes off-patent, profits plummet, as competitors flood the market with less-expensive competitors. There's already a ... Read moreChevron

Dr. Fran Cogen

Dr. Fran Cogen, Health Pro

Director, Child/Adolescent Diabetes Program at Children's Nat'l

"Safe at School" Bills and Diabetes Care in Children

Children and adolescents spend much of their waking time in the school setting for both academic and extracurricular activities. As such, it is essential that they be safe at school and allow parents and caregivers to proceed with their usual day-to-day activities.


Nurses, of course, are essential in the care of children in... Read moreChevron

posted 02/23/2015, comments (0)|
David Mendosa

David Mendosa, Health Guide

Medical Journalist Living with Diabetes and Author of Fitness and Photography for Fun,

The New Diabetes Breakfast

My usual breakfast has changed because of my new diet. But it’s better for me than the smoked salmon that I ate before as well as being even tastier.

More than seven years ago when I... Read moreChevron

Gretchen Becker

Gretchen Becker, Health Guide

Author, Humorist,

Is Type 2 Your Fault?

When you’re first diagnosed with type 2, you have to deal with major changes in your life. Many people have to deal with feelings of guilt as well: “I brought this on myself.” A double burden.


But is that true? Popular press articles take this point of view. They point out the undisputed link between... Read moreChevron

posted 02/17/2015, comments (0)|
Dr. Bill Quick

Dr. Bill Quick, Health Pro

Physician who is living with diabetes; editor of

Glucose-Responsive Insulin Could Be The Future Of Insulin

This past week, a press release announced positive results from a mouse-research study of a new insulin—one that adapts to the ambient blood glucose level (BGL) to keep the BGL stable. The press release calls this new insulin... Read moreChevron

posted 02/16/2015, comments (0)|

Ask a Question

Get answers from our experts and community members.

View all questions (2365) >